While the obvious answer is found in gender, age and racial inequity, the study of mid-life women’s sexual and reproductive health has historically been less profitable than fertility. Thankfully the “menopause market” is on the rise, which will hopefully drive more dollars into the evidence-based scientific research that is so badly needed to drive more safe, effective and personalized treatments for menopausal women.
Jennifer Vander Zalm
More By This AuthorWelcome to Herstasis Health Blogs. When women ask questions about their experiences with the menopausal transition, we listen! These blogs are full of good content that is relevant, helpful, and always developed with current science-based information.
We invite you to read and enjoy (and learn a few things at the same time)!
